4//SEC Filing
Lotvin Alan 4
Accession 0001127602-22-006291
CIK 0000064803other
Filed
Feb 22, 7:00 PM ET
Accepted
Feb 23, 4:26 PM ET
Size
16.8 KB
Accession
0001127602-22-006291
Insider Transaction Report
Form 4
Lotvin Alan
EVP, Transformation
Transactions
- Award
Common Stock
2022-02-21+85,971→ 147,312.369 total
Holdings
- 27,395
Stock Option
Exercise: $104.82From: 2017-04-01Exp: 2023-04-01→ Common Stock (27,395 underlying) - 70,702
Stock Option
Exercise: $54.19From: 2020-04-01Exp: 2029-04-01→ Common Stock (70,702 underlying) - 120,940
Stock Option
Exercise: $74.30From: 2022-04-01Exp: 2031-04-01→ Common Stock (120,940 underlying) - 30,005.656
Stock Unit
- 22,541
Stock Option
Exercise: $62.21From: 2019-04-01Exp: 2025-04-01→ Common Stock (22,541 underlying) - 140,797
Stock Option
Exercise: $58.34From: 2021-04-01Exp: 2030-04-01→ Common Stock (140,797 underlying) - 556.764
Phantom Stock Credits
Exercise: $1.00→ Common Stock (556.764 underlying) - 492(indirect: By Trust)
Common Stock
- 5,827
Common Stock (restricted)
- 32,911
Stock Option
Exercise: $78.05From: 2018-04-03Exp: 2024-04-03→ Common Stock (32,911 underlying)
Footnotes (10)
- [F1]Represents shares earned by the reporting person pursuant to certain performance stock units (the "PSUs"), which were granted to the reporting person under the Issuer's 2017 Incentive Compensation Plan on June 5, 2019. The PSUs were earned based on the attainment of certain performance metrics, which performance metrics were certified by the Management and Planning Committee of the Board of Directors of the Issuer on February 21, 2022.
- [F10]Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
- [F2]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F3]Reflects year-end company-match share credits under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person.
- [F4]Option became exercisable in four equal annual installments, commencing 4/1/2017.
- [F5]Option became exercisable in four equal annual installments, commencing 4/3/2018.
- [F6]Option became exercisable in four equal annual installments, commencing 4/1/2019.
- [F7]Option became exercisable in four equal annual installments, commencing 4/1/2020.
- [F8]The number of shares subject to the option were calculated using a 30-day average price.
- [F9]Option became exercisable in four equal annual installments, commencing 4/1/2021.
Documents
Issuer
CVS HEALTH Corp
CIK 0000064803
Entity typeother
Related Parties
1- filerCIK 0001472795
Filing Metadata
- Form type
- 4
- Filed
- Feb 22, 7:00 PM ET
- Accepted
- Feb 23, 4:26 PM ET
- Size
- 16.8 KB